Outcome of (177)Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer

SIMPLE SUMMARY: The risk of prostate cancer development, the second most commonly occurring cancer in men overall, increases strongly with age. About 10% of patients, however, are diagnosed with early-onset prostate cancer (age at diagnosis: ≤55 years). This is considered to be a distinct clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mader, Nicolai, Groener, Daniel, Tselis, Nikolaos, Banek, Séverine, Nagarajah, James, Grünwald, Frank, Sabet, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392017/
https://www.ncbi.nlm.nih.gov/pubmed/34439347
http://dx.doi.org/10.3390/cancers13164193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392017/
https://www.ncbi.nlm.nih.gov/pubmed/34439347
http://dx.doi.org/10.3390/cancers13164193

Ejemplares similares